English | Español

Allergan, Inc.
Ruth de Jauregui | Apr 22, 2017

Novartis teaming with Allergan in Phase IIb trial of non-alcoholic steatohepatitis treatment therapy
Tabitha Fleming | Jan 24, 2017

Allergan continues support for headache research

Jamie Barrand | Mar 20, 2016

New treatment available for bipolar disorder, schizophrenia
Jamie Barrand | Mar 17, 2016

Allergan's dry eye disease therapy receives prior approval supplement from FDA
Jamie Barrand | Dec 17, 2015

Allergan releases new therapy for irritable bowel syndrome
Jamie Barrand | Dec 7, 2015

Allergan partners with Rugen Therapeutics to develop autism, OCD therapies
Jamie Barrand | Oct 16, 2015

Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215
Jamie Barrand | Oct 14, 2015

Allergan releasing generic version of Invega in U.S.

Trending
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+ Pharmaceuticals
Patient Daily | Oct 8, 2025

American Lung Association launches campaign urging vaccinations against seasonal flu and respiratory illnesses